Impact of strict fluid management on the treatment outcome of clazosentan for cerebral vasospasm
Objective: Clazosentan (CLA) reduces cerebral vasospasm after aneurysmal subarachnoid hemorrhage (aSAH). However, adverse events including pulmonary edema were reported. We examined whether the strict management of fluid balance reduces the adverse events and improves patient outcomes. Methods: Pati...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2024-04-01
|
Series: | Brain Hemorrhages |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589238X2300061X |